Evidence map›Paper›PMID 26851395›Full record

ArticleInternational journal of surgery case reports2016

Two cases of cisplatin-induced permanent renal failure following neoadjuvant chemotherapy for esophageal cancer.

Tomohiko Sasaki, Satoru Motoyama, Atsushi Komatsuda, Hiroyuki Shibata, Yusuke Sato, Kei Yoshino, Akiyuki Wakita, Hajime Saito, Akira Anbai, Mario Jin and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of surgery case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  3. Developing better mouse models to study cisplatin-induced kidney injury.American journal of physiology. Renal physiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Tomohiko SasakiDepartment of Surgery, Akita University Graduate School of Medicine, Akita, Japan. Electronic address: sa-tomo@gipc.akita-u.ac.jp.
Satoru MotoyamaDepartment of Surgery, Comprehensive Cancer Control, Akita University Graduate School of Medicine, Akita, Japan.
Atsushi KomatsudaDepartment of Hematology, Oncology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
Hiroyuki ShibataDepartment of Clinical Oncology, Akita University Graduate School of Medicine, Akita, Japan.
Yusuke SatoDepartment of Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Kei YoshinoDepartment of Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Akiyuki WakitaDepartment of Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Hajime SaitoDepartment of Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Akira AnbaiRadiology, Akita University Graduate School of Medicine, Akita, Japan.
Mario JinGastroenterology, Akita University Graduate School of Medicine, Akita, Japan.
Yoshihiro MinamiyaDepartment of Surgery, Akita University Graduate School of Medicine, Akita, Japan.
Akita University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe experienced two esophageal cancer patients who developed severe acute renal failure after neoadjuvant chemotherapy with cisplatin and 5-fluorourasil. PRESENTATION OF CASE: After administration of cisplatin, their serum creatinine increased gradually until they required hemodialysis and their renal failure was permanent. In both cases, renal biopsy examination indicated partial recovery of the proximal tubule, but renal function did not recover. After these events, one patient underwent definitive radiotherapy and the other underwent esophagectomy for their esophageal cancers, while continuing dialysis. Both patients are alive without cancer recurrence. DISCUSSION: In these two cases of cisplatin-induced renal failure, renal biopsy examination showed only slight disorder of proximal tubules and tendency to recover.

conclusionAlthough cisplatin-related nephrotoxicity is a well-recognized complication, there have been few reports of renal failure requiring hemodialysis in cancer patients. In this report, we present their clinical courses and the pathological findings of cisplatin-related renal failure.

Indexed as

CisplatinEsophageal cancerNeoadjuvant chemotherapyRenal failure

Identifiers

PMID26851395
PMCPMC4818298
OpenAlexW2270876560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.